Alumis is advancing a late-stage portfolio of next-generation targeted therapies for immune-mediated diseases, designed to optimize impact and transform patient care - helping millions worldwide live healthier, fuller lives
Alumis is advancing a late-stage portfolio of next-generation targeted therapies for immune-mediated diseases, designed to optimize impact and transform patient care - helping millions worldwide live healthier, fuller lives.